星贝止咳颗粒核心有效成分识别策略:多成分定量、组织分布、口服生物利用度与镇咳效应整合研究
该研究以星贝止咳颗粒为模型,建立整合含量比例、组织靶向、生物利用度和药效贡献的多维策略识别核心有效成分。18批制剂中26个成分含量稳定,7个有效成分分布于肺和气管等靶组织,苦杏仁苷含量最高但口服生物利用度最低,甘草次酸含量最低但生物利用度最高。主要有效成分混合物在给药后1小时镇咳效果与星贝止咳颗粒相似,确定苦杏仁苷、麻黄碱、伪麻黄碱和甘草次酸为核心有效成分。
要点
- 星贝止咳颗粒18批制剂中26个成分含量稳定,前十大成分波动小。
- 7个有效成分分布于肺和气管等靶组织,4个成分在血浆与靶组织间分布比稳定。
- 苦杏仁苷、麻黄碱、伪麻黄碱和甘草次酸被确定为核心有效成分。
核心结论
- 提出「暴露-分布-效应」多维核心有效成分判定标准,成功应用于星贝止咳颗粒,突破传统「含量唯一」质控局限。
研究设计与样本
- 采用UPLC-TQ-MS/MS建立两种灵敏准确方法,用于星贝止咳颗粒成分定量、组织分布和口服生物利用度研究。
- 在18批制剂中定量26个成分,并在给药大鼠的肺和气管等组织中进行定量分析。
- 比较主要成分混合物与星贝止咳颗粒的镇咳效果。
主要发现
- 星贝止咳颗粒通过18批制剂中26个成分的含量评价显示质量稳定,前十大成分波动小。
- 7个有效成分分布于不同组织,尤其是靶组织肺和气管;4个成分在血浆与靶组织间显示稳定的分布比。
- 苦杏仁苷含量最高但口服生物利用度最低,甘草次酸含量最低但口服生物利用度最高。
- 主要有效成分混合物在给药后1小时镇咳效果与星贝止咳颗粒相似。
- 基于各成分血浆暴露比和靶组织浓度比,确定苦杏仁苷、麻黄碱、伪麻黄碱和甘草次酸为核心有效成分,甘草酸作为甘草次酸体内前体应成为核心质控指标。
关键数值与推荐
- 18批制剂中26个成分含量稳定,前十大成分波动小。
- 7个有效成分分布于靶组织肺和气管,4个成分血浆与靶组织分布比稳定。
- 苦杏仁苷含量最高但口服生物利用度最低,甘草次酸含量最低但口服生物利用度最高。
- 主要有效成分混合物在给药后1小时镇咳效果与星贝止咳颗粒相似。
- 核心有效成分:苦杏仁苷、麻黄碱、伪麻黄碱、甘草次酸;核心质控指标:甘草酸。
临床怎么用
- 可将苦杏仁苷、麻黄碱、伪麻黄碱和甘草次酸作为星贝止咳颗粒核心有效成分进行精准质量控制。
- 甘草酸作为甘草次酸体内前体,应纳入核心质控指标。
- 该多维策略可为中药复方核心有效成分识别与质控研究提供可复制模型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Xingbei Zhike granule (XBZK), a widely used Chinese patent medicine consisting of nine herbal medicines, is clinically used to clear lung qi, relieve cough, and reduce phlegm and is commonly prescribed for cough associated the syndromes of external cold and internal heat. However, its core effective components remain unclear. AIM OF STUDY: This study aims to develop a new strategy, integrating content proportion, tissue targeting, bioavailability, and pharmacodynamic contribution, to explore the core effective components for precise quality control of traditional Chinese medicine (TCM), using Xingbei Zhike granule (XBZK) as a model. MATERIALS AND METHODS: Two sensitive and accurate methods were developed and validated for component quantification, tissues distribution analysis, and OB studies of XBZK using Ultra-performance liquid chromatography with triple quadrupole mass spectrometry (UPLC-TQ-MS/MS). Then, the main compounds were quantified in XBZK and tissues, especially the lung and trachea from XBZK-administered rats. The antitussive effect of two mixtures of the identified main components was compared with that of XBZK. RESULTS: XBZK demonstrated stable quality via content evaluation of 26 components in 18 batches of preparations, with little fluctuation in the top ten components. Seven effective components were distributed in different tissues, especially target tissues (lung and trachea). Four components showed a stable distribution ratio between plasma and target tissues. Amygdalin, with the highest content, exhibited the lowest OB, while enoxolone, present at the lowest, possessed the highest OB. The mixtures of the main effective components demonstrated a similar efficacy to XBZK at 1 h post-administration. Further, based on the exposure ratio in plasma and concentration ratio in target tissues of each component, amygdalin, ephedrine, pseudoephedrine, and enoxolone were identified as the core effective components of XBZK, and glycyrrhizic acid, the precursor of enoxolone in vivo, should became its core quality control. CONCLUSIONS: This research proposes a multi-dimensional core effective component determination standard of "exposure - distribution - effect", with successful application in XBZK, breaking the limitation of the traditional "content-only" approach in TCM quality control research, and providing a replicable model for TCM quality control research.
引用
- Gao X, Yin M, Feng J, et al. Core effective components identifying strategy of Xingbei Zhike granule: integrating multi-component quantification, tissue distribution, oral bioavailability, and antitussive effect. J Ethnopharmacol. 2025. PMID: 40602502. doi:10.1016/j.jep.2025.120226
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。